- Home
- TPR vs VTRS Comparison
TPR vs VTRS Comparison
Compare TPR & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPR
- VTRS
- Stock Information
- Founded
- TPR 1941
- VTRS 1961
- Country
- TPR United States
- VTRS United States
- Employees
- TPR N/A
- VTRS N/A
- Industry
- TPR Apparel
- VTRS Medicinal Chemicals and Botanical Products
- Sector
- TPR Consumer Discretionary
- VTRS Health Care
- Exchange
- TPR Nasdaq
- VTRS Nasdaq
- Market Cap
- TPR 14.8B
- VTRS 15.6B
- IPO Year
- TPR 2000
- VTRS N/A
- Fundamental
- Price
- TPR $64.13
- VTRS $12.52
- Analyst Decision
- TPR Buy
- VTRS Hold
- Analyst Count
- TPR 16
- VTRS 3
- Target Price
- TPR $62.06
- VTRS $13.67
- AVG Volume (30 Days)
- TPR 6.3M
- VTRS 9.7M
- Earning Date
- TPR 02-06-2025
- VTRS 11-07-2024
- Dividend Yield
- TPR 2.18%
- VTRS 3.83%
- EPS Growth
- TPR N/A
- VTRS N/A
- EPS
- TPR 3.45
- VTRS N/A
- Revenue
- TPR $6,665,500,000.00
- VTRS $15,048,500,000.00
- Revenue This Year
- TPR $2.43
- VTRS N/A
- Revenue Next Year
- TPR $2.80
- VTRS N/A
- P/E Ratio
- TPR $18.60
- VTRS N/A
- Revenue Growth
- TPR N/A
- VTRS N/A
- 52 Week Low
- TPR $35.23
- VTRS $9.93
- 52 Week High
- TPR $65.30
- VTRS $13.62
- Technical
- Relative Strength Index (RSI)
- TPR 65.21
- VTRS 47.73
- Support Level
- TPR $62.03
- VTRS $12.07
- Resistance Level
- TPR $64.72
- VTRS $12.74
- Average True Range (ATR)
- TPR 1.71
- VTRS 0.33
- MACD
- TPR -0.42
- VTRS -0.10
- Stochastic Oscillator
- TPR 72.21
- VTRS 38.79
About TPR Tapestry Inc.
Coach, Kate Spade, and Stuart Weitzman are Tapestry's fashion and accessory brands. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (64% of fiscal 2024 sales), Europe, Asia (29% of fiscal 2024 sales), and elsewhere. Coach (76% of fiscal 2024 sales) is best known for affordable luxury leather products. Kate Spade (20% of fiscal 2023 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2024. Stuart Weitzman (4% of sales) generates virtually all its revenue from women's footwear.
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.